These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 17096692
1. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis. Hotta O, Ishida A, Kimura T, Taguma Y. Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692 [Abstract] [Full Text] [Related]
2. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis. Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, Fukatsu A, Kita T, Suzuki K, Muso E. Nephron Clin Pract; 2006 Oct; 102(1):c35-42. PubMed ID: 16174989 [Abstract] [Full Text] [Related]
3. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane. Lindic J, Vizjak A, Ferluga D, Kovac D, Ales A, Kveder R, Ponikvar R, Bren A. Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059 [Abstract] [Full Text] [Related]
4. Rapidly progressive glomerulonephritis: current and evolving treatment strategies. Little MA, Pusey CD. J Nephrol; 2004 Aug; 17 Suppl 8():S10-9. PubMed ID: 15599880 [Abstract] [Full Text] [Related]
5. [Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases]. Yoshihara R, Tanaka Y, Shiozawa K, Hayakawa M, Nagao M, Imura S. Ryumachi; 1996 Oct; 36(5):762-8. PubMed ID: 8969556 [Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan. Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K. Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757 [Abstract] [Full Text] [Related]
7. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Falk RJ, Nachman PH, Hogan SL, Jennette JC. Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933 [Abstract] [Full Text] [Related]
8. [Successful treatment of severe ANCA-associated RPGN with high-dose IVIg therapy]. Gomada M, Akamatsu A. Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):79-83. PubMed ID: 15058108 [Abstract] [Full Text] [Related]
11. Pauci-immune necrotizing glomerulonephritis. Rutgers A, Sanders JS, Stegeman CA, Kallenberg CG. Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250 [Abstract] [Full Text] [Related]
12. [Rapidly progressive ANCA-negative glomerulonephritis in the course of pauci immune microscopic vasculitis with hemolytic anemia probable in the course of Wilson's disease]. Wieczorek-Surdacka E, Kaczmarczyk I, Jasik P, Przepiórkowska-Hoyer B, Sułowicz W. Przegl Lek; 2011 Aug; 68(2):123-5. PubMed ID: 21751523 [Abstract] [Full Text] [Related]
13. Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors. Hasegawa M, Watanabe A, Takahashi H, Takahashi K, Kasugai M, Kawamura N, Kushimoto H, Murakami K, Tomita M, Nabeshima K, Oohashi A, Kondou F, Ooshima H, Hiki Y, Sugiyama S. Ther Apher Dial; 2005 Aug; 9(4):297-302. PubMed ID: 16076370 [Abstract] [Full Text] [Related]
20. Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis. Hasegawa M, Kawamura N, Murase M, Koide S, Kushimoto H, Murakami K, Tomita M, Hiki Y, Shikano M, Sugiyama S. Ther Apher Dial; 2004 Jun; 8(3):212-6. PubMed ID: 15154873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]